New Lifestyle for New Challenges!! | Dr. Sairam Atluri | TEDxKPRIT

Quick Overview

Dr. Sairam Atluri argues that chronic inflammation, or "inflammaging," is the primary driver of most modern diseases, responsible for 75% of healthcare costs and 20 million deaths annually, but this can be managed by adopting specific lifestyle changes and leveraging stem cell therapies, which are proven safe and effective.

Key Points: Chronic inflammation (termed "inflammaging") kills 20 million people annually and causes 75% of all deaths related to healthcare costs. The primary drivers of this chronic inflammation are modern food, poor lifestyle, pollution, and aging, which are largely controllable factors. The Nobel Prize Committee recognized the importance of T-reg cells (which decrease inflammation) and the discovery of T-reg cells 30 years ago. Stem cells are highlighted as the "Medical Innovation of the Century" by the World Economic Forum (2020) because they can reduce inflammation and regenerate damaged tissues, such as lungs. Clinical evidence, including 10 high-quality randomized control trials and a first-in-world animal trial involving stem cells and exosomes for liver failure, supports the safety and efficacy of stem cells. Lifestyle changes to combat inflammation include eating right, intermittent fasting, exercise, good sleep, minimizing stress and toxin exposure, and enjoying relationships. Dr. Atluri emphasizes that individuals have control over the 80% of inflammation caused by diet and lifestyle, allowing them to live healthier and longer lives.

Context: Dr. Sairam Atluri, Founder & CEO of Tulsi Therapeutics, presents at a TEDxKPRIT event, focusing on the pervasive threat of chronic inflammation, which he calls "inflammaging," linking it to major chronic diseases like heart attacks, cancer, and Alzheimer's. He contrasts the massive death toll from this silent epidemic with the promising therapeutic potential of stem cells, citing recent scientific recognition and clinical data to advocate for both lifestyle intervention and regenerative medicine.